DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

DLD Asset Management’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.81M	Buy	168,226 +2,791	+2%	+$30K	0.13%	112
2026 Q2	$1.77M	Buy	165,435 +28,700	+21%	+$306K	0.12%	110
2026 Q1	$1.45M	Buy	136,735 +1,200	+0.9%	+$12.8K	0.13%	117
2025 Q4	$1.43M	Buy	135,535 +9,346	+7%	+$98.9K	0.11%	125
2025 Q3	$1.33M	Buy	126,189 +26,189	+26%	+$274K	0.1%	133
2025 Q2	$1.04M	Sell	100,000 -250,000	-71%	-$2.59M	0.09%	121
2025 Q1	$3.58M	Buy	350,000 +175,000	+100%	+$1.76M	0.28%	45
2024 Q4	$1.74M	Buy	+175,000	New	+$1.75M	0.21%	53

Other funds holding OACC

Boussard & Gavaudan Gestion SAS Paris, France $1.29B AUM

Sculptor Capital New York $10.4B AUM 27.51% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $18B AUM 27.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $33B AUM 30.04% 1-Year Est. Return

Gritstone Asset Management Bethesda, Maryland $103M AUM 5.65% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.2B AUM 6.57% 1-Year Est. Return

DLD Asset Management's OACC Position: Q3 2026 in Review

DLD Asset Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 1.7% in Q3 2026, buying an estimated $30K and bringing the position to 168,226 shares worth $1.81M. The position accounts for 0.13% of the portfolio, ranked #112.

DLD Asset Management first reported a position in OACC in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.58M in Q1 2025. 20 funds tracked by Wall St. Rank hold OACC as of Q3 2026.

DLD Asset Management held 168,226 shares of Oaktree Acquisition Corp III Life Sciences worth $1.81M as of Q3 2026.
DLD Asset Management bought 2,791 Oaktree Acquisition Corp III Life Sciences shares in Q3 2026, an estimated $30K.
Oaktree Acquisition Corp III Life Sciences made up 0.13% of DLD Asset Management's portfolio in Q3 2026, its #112 holding.
DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 8 quarters since.
DLD Asset Management's Oaktree Acquisition Corp III Life Sciences position peaked at $3.58M in Q1 2025.
20 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.

Based on DLD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.